1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising demand for monitoring devices in the treatment of arrhythmia
5.1.1.2. Increasing cases of obesity and rising geriatric population
5.1.1.3. Rising trend of irrigated radiofrequency (RF) ablation catheter devices
5.1.1.4. Sedentary lifestyle coupled with rising consumption of alcohol & cigarettes
5.1.2. Restraints
5.1.2.1. Limitation of Holter recordings is very short sampling period to allow capture of an infrequent arrhythmia
5.1.3. Opportunities
5.1.3.1. Increasing research and development activities in the field
5.1.3.2. Extensive product pipeline
5.1.4. Challenges
5.1.4.1. High-cost devices
5.2. Cumulative Impact of COVID-19

6. Arrhythmia Market, by Site Of Origin Atrial
6.1. Introduction
6.2. Atrial tachycardia
6.3. Premature Atrial contractions
6.4. Sinus Bradycardia
6.5. Wandering Atrial Pacemaker

7. Arrhythmia Market, by Test Equipment
7.1. Introduction
7.2. Electrocardiogram
7.3. Holter monitor

8. Americas Arrhythmia Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Arrhythmia Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand

10. Europe, Middle East & Africa Arrhythmia Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Abbott Laboratories
12.2. ACSDiagnostics
12.3. AliveCor Inc
12.4. AtriCure Inc.
12.5. Biosense Webster, Inc.
12.6. Biotronik
12.7. Boston Scientific Corporation
12.8. CardioFocus, Inc.
12.9. CathEffects Inc.
12.10. CathRx Ltd.
12.11. EndoPhotonix, Inc.
12.12. Fukuda Denshi Co., Ltd.
12.13. GE Healthcare
12.14. GlaxoSmithKline LLC
12.15. iRhythm Technologies Inc
12.16. Koninklijke Philips NV
12.17. Mayne Pharma
12.18. Medi-Lynx
12.19. Medtronic PLC
12.20. Mylan N.V.
12.21. Nihon Kohden Corporation
12.22. Novartis International AG
12.23. NUUBO Smart Solutions Technologies, SL
12.24. Sanofi S.A.
12.25. Siemens AG
12.26. Spacelabs Healthcare, Inc. (OSI Systems, Inc.)
12.27. Upsher-Smith Laboratories LLC
12.28. Welch Allyn - A Hill-Rom Inc. Company

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL ARRHYTHMIA MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ARRHYTHMIA MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2020 VS 2027 (%)
FIGURE 4. GLOBAL ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2027
FIGURE 6. GLOBAL ARRHYTHMIA MARKET SIZE, BY ATRIAL TACHYCARDIA, 2018-2027 (USD MILLION)
FIGURE 7. GLOBAL ARRHYTHMIA MARKET SIZE, BY ATRIAL TACHYCARDIA, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 8. GLOBAL ARRHYTHMIA MARKET SIZE, BY PREMATURE ATRIAL CONTRACTIONS, 2018-2027 (USD MILLION)
FIGURE 9. GLOBAL ARRHYTHMIA MARKET SIZE, BY PREMATURE ATRIAL CONTRACTIONS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 10. GLOBAL ARRHYTHMIA MARKET SIZE, BY SINUS BRADYCARDIA, 2018-2027 (USD MILLION)
FIGURE 11. GLOBAL ARRHYTHMIA MARKET SIZE, BY SINUS BRADYCARDIA, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 12. GLOBAL ARRHYTHMIA MARKET SIZE, BY WANDERING ATRIAL PACEMAKER, 2018-2027 (USD MILLION)
FIGURE 13. GLOBAL ARRHYTHMIA MARKET SIZE, BY WANDERING ATRIAL PACEMAKER, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 14. GLOBAL ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2020 VS 2027 (%)
FIGURE 15. GLOBAL ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2020 VS 2027 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2027
FIGURE 17. GLOBAL ARRHYTHMIA MARKET SIZE, BY ELECTROCARDIOGRAM, 2018-2027 (USD MILLION)
FIGURE 18. GLOBAL ARRHYTHMIA MARKET SIZE, BY ELECTROCARDIOGRAM, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL ARRHYTHMIA MARKET SIZE, BY HOLTER MONITOR, 2018-2027 (USD MILLION)
FIGURE 20. GLOBAL ARRHYTHMIA MARKET SIZE, BY HOLTER MONITOR, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 21. AMERICAS ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 22. ARGENTINA ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 23. BRAZIL ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 24. CANADA ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 25. MEXICO ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 26. UNITED STATES ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 27. ASIA-PACIFIC ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 28. AUSTRALIA ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 29. CHINA ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 30. INDIA ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 31. INDONESIA ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 32. JAPAN ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 33. MALAYSIA ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 34. PHILIPPINES ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 35. SINGAPORE ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 36. SOUTH KOREA ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 37. TAIWAN ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 38. THAILAND ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 39. EUROPE, MIDDLE EAST & AFRICA ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 40. FRANCE ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 41. GERMANY ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 42. ITALY ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 43. NETHERLANDS ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 44. QATAR ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 45. RUSSIA ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 46. SAUDI ARABIA ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 47. SOUTH AFRICA ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 48. SPAIN ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. UNITED ARAB EMIRATES ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 50. UNITED KINGDOM ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 51. GLOBAL ARRHYTHMIA MARKET: FPNV POSITIONING MATRIX
FIGURE 52. GLOBAL ARRHYTHMIA MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 53. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ARRHYTHMIA MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL ARRHYTHMIA MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL ARRHYTHMIA MARKET SIZE, BY ATRIAL TACHYCARDIA, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL ARRHYTHMIA MARKET SIZE, BY PREMATURE ATRIAL CONTRACTIONS, BY REGION, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL ARRHYTHMIA MARKET SIZE, BY SINUS BRADYCARDIA, BY REGION, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL ARRHYTHMIA MARKET SIZE, BY WANDERING ATRIAL PACEMAKER, BY REGION, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL ARRHYTHMIA MARKET SIZE, BY ELECTROCARDIOGRAM, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL ARRHYTHMIA MARKET SIZE, BY HOLTER MONITOR, BY REGION, 2018-2027 (USD MILLION)
TABLE 11. AMERICAS ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 12. ARGENTINA ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 13. BRAZIL ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 14. CANADA ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 15. MEXICO ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 17. ASIA-PACIFIC ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 18. AUSTRALIA ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 19. CHINA ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 20. INDIA ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 21. INDONESIA ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 22. JAPAN ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 23. MALAYSIA ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 24. PHILIPPINES ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 25. SINGAPORE ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 26. SOUTH KOREA ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 27. TAIWAN ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 28. THAILAND ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 30. FRANCE ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 31. GERMANY ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 32. ITALY ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 33. NETHERLANDS ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 34. QATAR ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 35. RUSSIA ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 36. SAUDI ARABIA ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 37. SOUTH AFRICA ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 38. SPAIN ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 39. UNITED ARAB EMIRATES ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 40. UNITED KINGDOM ARRHYTHMIA MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 41. GLOBAL ARRHYTHMIA MARKET: SCORES
TABLE 42. GLOBAL ARRHYTHMIA MARKET: BUSINESS STRATEGY
TABLE 43. GLOBAL ARRHYTHMIA MARKET: PRODUCT SATISFACTION
TABLE 44. GLOBAL ARRHYTHMIA MARKET: RANKING
TABLE 45. GLOBAL ARRHYTHMIA MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 46. GLOBAL ARRHYTHMIA MARKET: MERGER & ACQUISITION
TABLE 47. GLOBAL ARRHYTHMIA MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 48. GLOBAL ARRHYTHMIA MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 49. GLOBAL ARRHYTHMIA MARKET: INVESTMENT & FUNDING
TABLE 50. GLOBAL ARRHYTHMIA MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 51. GLOBAL ARRHYTHMIA MARKET: LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
ACSDiagnostics
AliveCor Inc
AtriCure Inc.
Biosense Webster, Inc.
Biotronik
Boston Scientific Corporation
CardioFocus, Inc.
CathEffects Inc.
CathRx Ltd.
EndoPhotonix, Inc.
Fukuda Denshi Co., Ltd.
GE Healthcare
GlaxoSmithKline LLC
iRhythm Technologies Inc
Koninklijke Philips NV
Mayne Pharma
Medi-Lynx
Medtronic PLC
Mylan N.V.
Nihon Kohden Corporation
Novartis International AG
NUUBO Smart Solutions Technologies, SL
Sanofi S.A.
Siemens AG
Spacelabs Healthcare, Inc. (OSI Systems, Inc.)
Upsher-Smith Laboratories LLC
Welch Allyn - A Hill-Rom Inc. Company